CY1124596T1 - Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση - Google Patents
Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρησηInfo
- Publication number
- CY1124596T1 CY1124596T1 CY20211100642T CY211100642T CY1124596T1 CY 1124596 T1 CY1124596 T1 CY 1124596T1 CY 20211100642 T CY20211100642 T CY 20211100642T CY 211100642 T CY211100642 T CY 211100642T CY 1124596 T1 CY1124596 T1 CY 1124596T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- tramadol
- ophthalmic use
- eye
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με μια φαρμακευτική σύνθεση τρομαδόλης για οφθαλμική χρήση. Η σύνθεση χαρακτηρίζεται από το ότι περιέχει τραμαδόλη σε μια χαμηλή συγκέντρωση, ειδικά μεταξύ 0,02% και 0,09%, και από το ότι είναι πολύ αποτελεσματική στη θεραπεία του οφθαλμικού πόνου, για παράδειγμα ακολουθώντας τραυματισμούς ή χειρουργική επέμβαση στους οφθαλμούς, ή ο οφθαλμικός πόνος συνδέεται με το σύνδρομο ξηροφθαλμίας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201500657A ES2604816B1 (es) | 2015-09-09 | 2015-09-09 | Composición farmacéutica de tramadol para uso oftálmico |
PCT/ES2016/000092 WO2017042404A1 (es) | 2015-09-09 | 2016-09-05 | Composición farmacéutica de tramadol para uso oftálmico |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124596T1 true CY1124596T1 (el) | 2022-07-22 |
Family
ID=58208846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100642T CY1124596T1 (el) | 2015-09-09 | 2021-07-16 | Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190224114A1 (el) |
EP (1) | EP3348260B1 (el) |
CY (1) | CY1124596T1 (el) |
DK (1) | DK3348260T3 (el) |
ES (2) | ES2604816B1 (el) |
HR (1) | HRP20211181T1 (el) |
HU (1) | HUE054930T2 (el) |
PL (1) | PL3348260T3 (el) |
PT (1) | PT3348260T (el) |
RU (1) | RU2744570C2 (el) |
WO (1) | WO2017042404A1 (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2604816B1 (es) | 2015-09-09 | 2018-01-29 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
US11103452B2 (en) * | 2019-11-08 | 2021-08-31 | Athena Bioscience, Llc | Tramadol hydrochloride solution |
IT202000015457A1 (it) * | 2020-06-26 | 2021-12-26 | Sifi Spa | Composizione oftalmica e suo uso nel trattamento di patologie dell’occhio |
WO2024010045A1 (ja) * | 2022-07-06 | 2024-01-11 | 学校法人金沢医科大学 | 疼痛抑制剤 |
TW202408472A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
TW202408467A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
TW202408468A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
TW202408473A (zh) * | 2022-07-06 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
US7893040B2 (en) * | 2005-07-22 | 2011-02-22 | Oculis Ehf | Cyclodextrin nanotechnology for ophthalmic drug delivery |
ITMI20052036A1 (it) * | 2005-10-26 | 2007-04-27 | Professional Dietetics Srl | Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato |
JP6148664B2 (ja) * | 2011-04-05 | 2017-06-14 | オプトソルヴ リサーチ アンド ディベロップメント リミテッド | 眼科治療 |
GB201217522D0 (en) * | 2012-10-01 | 2012-11-14 | Sharma Anant | ophthalmic therapy |
ES2540151B1 (es) * | 2013-10-11 | 2016-02-29 | Farmalider S.A. | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
ES2604816B1 (es) | 2015-09-09 | 2018-01-29 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
-
2015
- 2015-09-09 ES ES201500657A patent/ES2604816B1/es active Active
-
2016
- 2016-09-05 WO PCT/ES2016/000092 patent/WO2017042404A1/es active Application Filing
- 2016-09-05 PL PL16843709T patent/PL3348260T3/pl unknown
- 2016-09-05 RU RU2018112239A patent/RU2744570C2/ru active
- 2016-09-05 US US15/758,849 patent/US20190224114A1/en not_active Abandoned
- 2016-09-05 EP EP16843709.3A patent/EP3348260B1/en active Active
- 2016-09-05 DK DK16843709.3T patent/DK3348260T3/da active
- 2016-09-05 ES ES16843709T patent/ES2882116T3/es active Active
- 2016-09-05 PT PT168437093T patent/PT3348260T/pt unknown
- 2016-09-05 HU HUE16843709A patent/HUE054930T2/hu unknown
-
2021
- 2021-07-16 CY CY20211100642T patent/CY1124596T1/el unknown
- 2021-07-22 HR HRP20211181TT patent/HRP20211181T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017042404A1 (es) | 2017-03-16 |
ES2604816A1 (es) | 2017-03-09 |
ES2604816B1 (es) | 2018-01-29 |
PT3348260T (pt) | 2021-08-06 |
US20190224114A1 (en) | 2019-07-25 |
HUE054930T2 (hu) | 2021-10-28 |
PL3348260T3 (pl) | 2021-12-06 |
RU2744570C2 (ru) | 2021-03-11 |
RU2018112239A3 (el) | 2020-01-30 |
EP3348260A1 (en) | 2018-07-18 |
DK3348260T3 (da) | 2021-07-05 |
ES2882116T3 (es) | 2021-12-01 |
HRP20211181T1 (hr) | 2021-10-15 |
RU2018112239A (ru) | 2019-10-09 |
EP3348260A4 (en) | 2019-04-17 |
EP3348260B1 (en) | 2021-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124596T1 (el) | Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση | |
CY1120729T1 (el) | Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων | |
CY1122832T1 (el) | Σουλφονυλουριες και σχετικες ενωσεις και χρηση αυτων | |
CY1122122T1 (el) | Υδατικο οφθαλμικο διαλυμα και μεθοδος για τη θεραπευτικη αγωγη συνδρομου ξηρου οφθαλμου | |
CY1124407T1 (el) | Ενωσεις αναστολεα αυτοταξινης | |
CY1125025T1 (el) | 2-φορμυλ-3-υδροξυφαινυλοξυμεθυλ ενωσεις ικανες ρυθμισης αιμοσφαιρινης | |
BR112019006160A2 (pt) | composições e métodos para o tratamento das condições oftálmicas | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201990043A1 (ru) | Антибактериальные соединения | |
BR112017010173A2 (pt) | composição para tratamento de tecido | |
CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
CY1123963T1 (el) | Καινοτομα πολυμερικα προφαρμακα hgh | |
EA201692109A1 (ru) | Варианты антител к фактору d и их применение | |
CY1123947T1 (el) | Βελτιστοποιημενος υποκινητης rpe65 και βελτιστοποιημενες κωδικοποιητικες αλληλουχιες | |
EA201991073A1 (ru) | Ингибиторы magl | |
BR112017010177A2 (pt) | composição para tratamento de tecido | |
CY1122818T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου | |
EA201991074A1 (ru) | Ингибиторы magl | |
CY1123366T1 (el) | Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου | |
CY1120642T1 (el) | Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση | |
MX2016010328A (es) | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. | |
CY1121187T1 (el) | Ενα εκχυλισμα απο indigo naturalis και μια διεργασια για την παρασκευη εκεινου | |
CY1122882T1 (el) | Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
CY1120573T1 (el) | Παραγωγα πυριδαζινης για χρηση στην προληψη ή θεραπεια αταξικης διαταραχης | |
CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου |